KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Cash from Investing Activities (2016 - 2025)

Eli Lilly (LLY) has disclosed Cash from Investing Activities for 17 consecutive years, with -$2.8 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities fell 45.87% year-over-year to -$2.8 billion, compared with a TTM value of -$11.0 billion through Dec 2025, down 17.95%, and an annual FY2025 reading of -$11.0 billion, down 17.95% over the prior year.
  • Cash from Investing Activities was -$2.8 billion for Q4 2025 at Eli Lilly, up from -$3.0 billion in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$459.1 million in Q2 2023 and bottomed at -$4.0 billion in Q3 2024.
  • Average Cash from Investing Activities over 5 years is -$1.7 billion, with a median of -$1.2 billion recorded in 2021.
  • The sharpest move saw Cash from Investing Activities surged 44.45% in 2023, then tumbled 378.92% in 2024.
  • Year by year, Cash from Investing Activities stood at -$484.2 million in 2021, then crashed by 94.86% to -$943.5 million in 2022, then tumbled by 209.97% to -$2.9 billion in 2023, then surged by 34.32% to -$1.9 billion in 2024, then plummeted by 45.87% to -$2.8 billion in 2025.
  • Business Quant data shows Cash from Investing Activities for LLY at -$2.8 billion in Q4 2025, -$3.0 billion in Q3 2025, and -$1.8 billion in Q2 2025.